Assessment of the efficacy and safety of antiarrhythmic therapy for chronic atrial fibrillation: Observations on the role of trial design and implications of drug-related mortality
- 31 October 1992
- journal article
- research article
- Published by Elsevier BV in American Heart Journal
- Vol. 124 (4), 924-932
- https://doi.org/10.1016/0002-8703(92)90974-z
Abstract
No abstract availableThis publication has 34 references indexed in Scilit:
- Preliminary Report of the Stroke Prevention in Atrial Fibrillation StudyThe New England Journal of Medicine, 1990
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986
- Incidence and clinical features of the quinidine-associated long QT syndrome: Implications for patient careAmerican Heart Journal, 1986
- Beta blockade during and after myocardial infarction: An overview of the randomized trialsProgress in Cardiovascular Diseases, 1985
- Antiarrhythmic Drugs: a Possible Cause of Out-of-Hospital Cardiac ArrestThe New England Journal of Medicine, 1983
- A method for assessing the quality of a randomized control trialControlled Clinical Trials, 1981
- COMPARATIVE EFFICIENCY OF QUINIDINE AND VERAPAMIL IN THE MAINTENANCE OF SINUS RHYTHM AFTER DC CONVERSION OF ATRIAL FIBRILLATION A CONTROLLED CLINICAL TRIALActa Medica Scandinavica, 1981
- Evidence Favoring the Use of Anticoagulants in the Hospital Phase of Acute Myocardial InfarctionThe New England Journal of Medicine, 1977
- Quinidine SyncopeCirculation, 1964
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958